
Assistant professor, Department of Pharmacy, University of Copenhagen
The scientific and commercial prominence of biopharmaceuticals, currently mostly referred to as biotherapeutics, is beyond dispute. However, the complexity of pharmaceutical formulation design, development, and assessment poses great challenges in the process of developing novel safe medicines. In this course, leading experts in the field present selected topics and use case-based approaches to introduce examples of some of the newest advances related to different parts of the drug development process.
This course provides an overview of the drug development process and highlights crucial aspects of specific importance for the capability to develop biologically active macromolecules like peptides, antibodies, RNA oligonucleotides, and other biological material into effective medicines.
At first sight, utilization of biotherapeutics as drugs appears straightforward since the pharmacological activity of endogenous compounds such as hormones and coagulation factors are given. Due to tremendous advances in understanding disease biology, new targets for therapeutics are continuously identified, and this excels novel opportunities for new and improved products. Provided that the potent macromolecules or other biological material is druggable. This requires efficient formulation designs and novel delivery approaches, which are continuously emerging. Also, due to the structural complexity and instability of the active material, drug development requires specific processes and models for efficacy testing and safety assessment.
I got a great overview of the topic and many great talks!
During the course you will:
The course will address and highlight characteristics and procedures of relevance for the design and development of biotherapeutics. Experts from relevant fields will lecture on and discuss both fundamental concepts and specific selected issues related to biotherapeutics drug development.
Topics of special attention are picked from the discovery phase through development and assessment, and include e.g. molecular engineering, pharmaceutical drug design and formulation, experimental models, efficacy and safety assessment and regulatory aspects. Case studies will form the basis for interactive discussion sessions.
The course is for professionals in the pharmaceutical industry who need an interdisciplinary overview of the specific requirements for the development of biotherapeutics. The University of Copenhagen has preapproved the course as an elective in the Master of Industrial Drug Development (MIND) programme and the Master of Medicines Regulatory Affairs (MRA) programme.
Participants must:
This is a 5-day course that runs in the period 14-18 August 2023 from approx. 09:00-16:30.
Dates for examination can be found in the exam schedule.
You may find relevant information about the exam in the course curriculum.
University of Copenhagen
South Campus, Faculty of Law
Njalsgade 76
DK-2300 København S
Denmark
Copenhagen Summer University
csu@adm.ku.dk
+45 3533 3423
14-18 August 2023
09:00-16:30
Great course! I learned a lot and enjoyed discussing with the other participants
It has been a very inspiring week!
Very Nice. Fantastic skills and ability to wrap up over the week.